Jasper Therapeutics, Inc. (JSPR) bonds
JSPRNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
$13.68+0.31 (+2.32%)
Close on Nov 13, 2026Market cap $455.20MP/E –Yield –
Debt
Borrowings on the balance sheet, Jun 30, 2026
Jasper Therapeutics reports no long-term debt line
Its balance sheet in XBRL does not include long-term debt, so totals and interest cost cannot be shown.
Notes and loans outstanding
As tagged in Jasper Therapeutics's 10-K for the period ended Dec 31, 2023
| Issue | Coupon |
|---|---|
| lease Term | 9.00% |
Companies tag their debt differently: some list every note, others group notes by issuance year or by type, so the list may not add up to total debt. Notes that matured before today are hidden. Source: 10-K.
See a number that looks wrong?